Form 4: AnaptysBio Director Sells $193K in Common Stock

AnaptysBio director J. Anthony Ware sold 3,900 shares of common stock for approximately $193,342.50 on December 23, 2025.

Summary

• J. Anthony Ware, a director of ANAPTYSBIO, INC (ANAB), reported a transaction involving the company's common stock.
• On December 23, 2025, Mr. Ware disposed of 3,900 shares of common stock.
• The shares were sold at a price of $49.575 per share.
• Following this transaction, Mr. Ware directly beneficially owns 9,630 shares of common stock.
• In addition to the common stock, Mr. Ware holds options to purchase up to 126,085 shares of common stock and 6,030 restricted stock units.

Sentiment

Score: 4

Explanation: The sale of shares by a director, while not a massive divestment, is generally perceived as a slightly negative signal by the market, indicating a potential lack of strong conviction in future upside or a need for personal liquidity.

Negatives

• A director, J. Anthony Ware, sold 3,900 shares of common stock, representing a divestment of direct holdings.

Industry Context

This filing reports a routine insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders may interpret the director's sale as a signal regarding the company's future prospects, potentially influencing investor sentiment.

Key Dates

Keywords

AnaptysBio, ANAB, Insider Trading, Form 4, Director Sale, Stock Transaction, Biotechnology